Stockreport

BridgeBio Pharma Has 20% Upside Growth Potential, Morgan Stanley Says [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF BridgeBio Pharma (BBIO) could see more than 20% upside, driven by its commercial-stage drug Attruby [Read more]